News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|March 28, 2018

An American Journal of Managed Care Medical Crossfire: Management of Newer Ultra-Long Acting Basal Insulin Agents in Diabetes

https://www.pharmacytimes.org/landing/1139

https://www.pharmacytimes.org/landing/1139

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Dr Katherine Tobon

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

ByBrooke McCormick,Katherine Tobon, PharmD, BCOP

February 7th 2026

Patients spoke of navigating unwritten social rules around who could know about their hair loss and when concealment was expected. | Image credit: Creative Cat Studio - stock.adobe.com

Exploring Identity, Appearance Experiences Among Patients With Alopecia

ByAJMC Contributor

February 6th 2026

pill with water -New Africa - stock.adobe.com

5 Things to Know About the Oral GLP-1 Era

ByGiuliana Grossi

February 6th 2026

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

February 6th 2026

The mechanistic role of HP in CSU remains unclear, and whether HP is merely a marker of inflammation or an active contributor to disease processes warrants further investigation. | Image Credit: stock.adobe.com

Potential Predictor of Treatment Response in Chronic Spontaneous Urticaria Identified

ByAJMC Contributor

February 6th 2026

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text